Statistics for Centessa Pharmaceuticals Limited (id:7817 CNTA)

Valuation metrics

Market cap

2.24B

Enterprise value

1.72B

Trailing P/E (ttm)

-10.66

Forward P/E

-9.94

PEG ratio

-9.94

Price/Sales (ttm)

327.06

Price/Book (mrq)

6.70

Enterprise Value/Revenue

250.57

Enterprise Value/EBITDA

-11.07

Overview

Shares outstanding

128.57M

Float

76.54M

Shares short

2.15M

% Held by insiders

0.01%

% Held by institutions

0.79%

Average volume (10 days)

499.38K

Average volume (90 days)

Price summary

52-Week low

5.58

52-Week high

18.74

52-Week change

59.68%

Beta

1.48

50-Day moving average

15.67

200-Day moving average

11.50

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-2,268.45%

Operational effectiveness

Return on assets

-24.54%

Return on equity

-55.84%

Income statement

Revenue (ttm)

0.07

Revenue per share (ttm)

0.07

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-155,099,008.00

Net income to common (ttm)

-157,347,008.00

Diluted EPS (ttm)

-1.55

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

294.83M

Total cash per share (mrq)

2.60

Total debt (mrq)

85.65M

Total Debt/Equity (mrq)

29.85

Current ratio (mrq)

1.33K%

Book value per share (mrq)

2.54

Cash flow

Cash flow statement

-146,308,000.00

Levered free cash flow (LFCF)

-91,917,752.00